First Report on the Isolation of <i>Salmonella enterica</i> subsp. <i>enterica</i> Serovar Hofit in Wild Boars ( <i>Sus scrofa</i> ) in Türkiye

The aim of this study was to isolate potential bacterial pathogens, such as <i>Salmonella</i> spp., from wild boars (<i>Sus scrofa</i>) inhabiting the Southern Marmara Region of Türkiye and to evaluate the <i>in vitro</i> antibiotic susceptibility of the isolates. Samples, including feces and internal organs (lymph nodes, liver, lungs, kidneys, and spleen), were collected from a total of 34 legally hunted wild boars. <i>Salmonella enterica</i> subsp. <i>enterica</i> serovar Hofit was isolated from 6 (17.6%) animals. Ciprofloxacin, streptomycin, ampicillin, tetracycline, chloramphenicol, enrofloxacin, gentamicin, ceftiofur, cefoxitin, nalidixic acid, amoxicillin/clavulanic acid, and trimethoprim/ sulfamethoxazole discs were used to determine the <i>in vitro</i> antimicrobial susceptibility of <i>S.</i> Hofit isolates. All <i>S.</i> Hofit isolates had 100% sensitivity to 11 of the antibiotics tested, and three isolates were resistant only to streptomycin. As a result, this study is the first to report the isolation of <i>S.</i> Hofit from wild boars worldwide. The high isolation rate (17.6%) suggests a potential adaptation of this serovar to swine hosts. The apparent prevalence of <i>S.</i> Hofit in wild boars raises concerns not only for wildlife but also for potential public health implications.